Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,517.01
(
0.58%
)
US TECH 100
29,198.80
(
1.73%
)
Dow Jones
50,396.31
(
-0.36%
)
Brent Oil
96.58
(
-4.54%
)
Bitcoin
75,935.72
(
-1.73%
)
News Focus
News Focus
Post# of 29254
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

bazirgani

Send PM Follow Ignore
Followers 0
Posts 138
Boards Moderated 0
Alias Born 06/29/2011

bazirgani

Re: Skeptical post# 13618

Wednesday, 05/16/2012 11:13:47 AM

Wednesday, May 16, 2012 11:13:47 AM

Post# of 29254
Viropro estimates the combined, aggregate realizable value of its biosimilars portfolio to be in the range of $33 million to $42 million, depending upon market dynamics of the individual products."
based on this current value and number of shares at 916 millions:
Share price baseline should be $ 0.0458
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote